OCUL: Morgan Stanley files to sell 1,858 shares

OCUL notice: Morgan Stanley Smith Barney LLC submitted a Rule 144 notice to sell 1,858 shares of Common Stock relating to restricted stock vesting under a registered plan dated 05/22/2026.

Rhea-AI Filing Summary

OCUL notice: Morgan Stanley Smith Barney LLC submitted a Rule 144 notice to sell 1,858 shares of Common Stock relating to restricted stock vesting under a registered plan dated 05/22/2026. The filing lists a company reference date of 05/26/2026.

Insights

Securities Attorney

Routine Rule 144 notice for vested restricted shares; no new proceeds or pricing disclosed.

Record shows a broker-dealer, Morgan Stanley Smith Barney LLC, submitting a notice to sell 1,858 shares of Common Stock tied to restricted stock vesting under a registered plan on 05/22/2026. The filing format indicates an intended resale under Rule 144; it does not state sale price or expected timing.

Cash-flow treatment and methods of sale are not specified in the excerpt; subsequent sale activity, pricing, or additional disclosures would appear in trading reports or later filings.

Key Figures

Shares offered (Rule 144 notice): 1,858 shares Filing reference date: 05/26/2026

2 metrics

Shares offered (Rule 144 notice) 1,858 shares restricted stock vesting under a registered plan on <date>05/22/2026</date>

Filing reference date 05/26/2026 company reference date listed in the excerpt

Key Terms

restricted stock vesting, registered plan, Rule 144

3 terms

restricted stock vesting financial

"Restricted stock vesting under a registered plan"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

registered plan regulatory

"Restricted stock vesting under a registered plan"

A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.

Rule 144 regulatory

"form_type: 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OCUL Form 144 filing report?

The filing reports a broker-dealer notice to sell 1,858 shares of Common Stock tied to restricted stock vesting. It records the vesting date as 05/22/2026 and a company reference date of 05/26/2026.

Who is listed as the selling holder in the OCUL filing?

The selling holder is Morgan Stanley Smith Barney LLC, Executive Financial Services. The filing lists their New York address and identifies the sale as tied to a restricted stock vesting under a registered plan.

Does the Form 144 disclose the sale price or proceeds for OCUL shares?

No. The excerpt does not disclose a sale price, total proceeds, or the planned sale method. It records only the share count (1,858 shares) and the vesting date; pricing and timing are not provided in the excerpt.

Does this OCUL filing change outstanding share counts or control?

The excerpt lists a large numeric value alongside the company date but does not explicitly tie it to outstanding shares or control changes. The filing is a resale notice and does not by itself alter outstanding share counts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 04:30 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002012715
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OCULAR THERAPEUTIX, INC.
SEC File Number	001-36554
Address of Issuer	15 Crosby Drive Bedford MASSACHUSETTS 01730
Phone	(781) 357-4000
Name of Person for Whose Account the Securities are To Be Sold	SANJAY NAYAK
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1858	15236.53	218960358	05/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/22/2026	Restricted stock vesting under a registered plan	Issuer			1858	05/22/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sanjay Nayak
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)